News Secukinumab Fails to Show Benefit in Graves’ Orbitopathy by Medscape • 2025/12/16 • 0 Comments Secukinumab does not show greater clinical efficacy than placebo in patients with moderate-to-severe Graves' orbitopathy, according to the ORBIT study. Medscape News UK